CTNM vs GIS · $429.6M cap vs P/E 8.2, rev $18.42B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
CTNM currently screens at market cap $429.6M. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the CTNM and GIS stock pages for the full models.
Not investment advice.